Mar 11, 2024
We must increase our nation's energy security, while at the same time addressing the global climate crisis.
Ben Ray Luján
The Public Record
Ben Ray Luján is an American politician serving as the junior United States senator from New Mexico since January 3, 2021. A member of the Democratic Party, he previously represented New Mexico's 3rd congressional district in the U.S. House of Representatives from 2009 to 2021. Luján has focused on various issues during his tenure, including economic development, healthcare, and tribal food security, advocating for policies that support New Mexico's diverse communities.
congress.gov
Feb 8, 2024
Biosimilar competition is one way to drive down drug costs for patients and increase access.
Feb 8, 2024
we see a legacy portfolio of well-established products facing headwinds such as IRA.
Feb 8, 2024
When the most relevant patents for OPDIVO expire, we would fully expect biosimilars to enter the market.
Feb 8, 2024
this portfolio--though the portfolio is declining, it is expected to continue to generate strong cash-flows to enable investment in our future growth drivers.
Feb 8, 2024
Biosimilar competition is one way to drive down drug costs for patients and increase access.
Feb 8, 2024
I fully expect, and I will not try to stop a biosimilar IV version of KEYTRUDA coming on to the marketplace.
Feb 8, 2024
the IRA's real victim is innovation, and in turn, the millions of patients who are counting on the pharmaceutical industry to develop new therapies, will save lives, and improve health and well-being.
Feb 8, 2024
this portfolio--though the portfolio is declining, it is expected to continue to generate strong cash-flows to enable investment in our future growth drivers.
Feb 8, 2024
When the most relevant patents expire on ELIQUIS, we will welcome generic competition.
Feb 8, 2024
we see a legacy portfolio of well-established products facing headwinds such as IRA.
Politicians like Ben Ray Luján
